These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28024455)

  • 1. The Neisseria meningitidis lpxL1 mutant induces less tissue factor expression and activity in primary human monocytes and monocyte-derived microvesicles than the wild type meningococcus.
    Hellum M; Trøseid AS; Berg JP; Brandtzaeg P; Øvstebø R; Henriksson CE
    Innate Immun; 2017 Feb; 23(2):196-205. PubMed ID: 28024455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression.
    Øvstebø R; Aass HC; Haug KB; Trøseid AM; Gopinathan U; Kierulf P; Berg JP; Brandtzaeg P; Henriksson CE
    Innate Immun; 2012 Aug; 18(4):580-91. PubMed ID: 22180561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-blood incubation with the Neisseria meningitidis lpxL1 mutant induces less pro-inflammatory cytokines than the wild type, and IL-10 reduces the MyD88-dependent cytokines.
    Aass HCD; Hellum M; Trøseid AS; Brandtzaeg P; Berg JP; Øvstebø R; Henriksson CE
    Innate Immun; 2018 Feb; 24(2):101-111. PubMed ID: 29313733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microparticle-associated tissue factor activity is reduced by inhibition of the complement protein 5 in Neisseria meningitidis-exposed whole blood.
    Øvstebø R; Hellum M; Aass HC; Trøseid AM; Brandtzaeg P; Mollnes TE; Henriksson CE
    Innate Immun; 2014 Jul; 20(5):552-60. PubMed ID: 24051102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy.
    Fransen F; Heckenberg SG; Hamstra HJ; Feller M; Boog CJ; van Putten JP; van de Beek D; van der Ende A; van der Ley P
    PLoS Pathog; 2009 Apr; 5(4):e1000396. PubMed ID: 19390612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity.
    Arenas J; van Dijken H; Kuipers B; Hamstra HJ; Tommassen J; van der Ley P
    Clin Vaccine Immunol; 2010 Apr; 17(4):487-95. PubMed ID: 20107001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide engineering in Neisseria meningitidis: structural analysis of different pentaacyl lipid A mutants and comparison of their modified agonist properties.
    Pupo E; Hamstra HJ; Meiring H; van der Ley P
    J Biol Chem; 2014 Mar; 289(12):8668-80. PubMed ID: 24492609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease.
    Fransen F; Hamstra HJ; Boog CJ; van Putten JP; van den Dobbelsteen GP; van der Ley P
    Infect Immun; 2010 Jul; 78(7):3177-86. PubMed ID: 20439476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.
    van der Ley P; Steeghs L; Hamstra HJ; ten Hove J; Zomer B; van Alphen L
    Infect Immun; 2001 Oct; 69(10):5981-90. PubMed ID: 11553534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production.
    Sprong T; Ley Pv; Abdollahi-Roodsaz S; Joosten L; Meer Jv; Netea M; Deuren Mv
    Innate Immun; 2011 Dec; 17(6):517-25. PubMed ID: 21088052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adults.
    du Plessis M; Wolter N; Crowther-Gibson P; Hamstra HJ; Schipper K; Moodley C; Cohen C; van de Beek D; van der Ley P; von Gottberg A; van der Ende A
    J Infect; 2014 May; 68(5):455-61. PubMed ID: 24393652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis.
    Steeghs L; Keestra AM; van Mourik A; Uronen-Hansson H; van der Ley P; Callard R; Klein N; van Putten JP
    Infect Immun; 2008 Aug; 76(8):3801-7. PubMed ID: 18490457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock.
    Hellum M; Øvstebø R; Brusletto BS; Berg JP; Brandtzaeg P; Henriksson CE
    Thromb Res; 2014 Mar; 133(3):507-14. PubMed ID: 24423888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pregnant woman with chronic meningococcaemia from Neisseria meningitidis with lpxL1-mutations.
    Persa OD; Jazmati N; Robinson N; Wolke M; Kremer K; Schweer K; Plum G; Schlaak M
    Lancet; 2014 Nov; 384(9957):1900. PubMed ID: 25457917
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of chronic meningococcemia with infection by meningococci with underacylated lipopolysaccharide.
    Brouwer MC; Spanjaard L; Prins JM; van der Ley P; van de Beek D; van der Ende A
    J Infect; 2011 Jun; 62(6):479-83. PubMed ID: 21459106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical contribution of both CD28 and ICOS in the adjuvant activity of Neisseria meningitidis H44/76 LPS and lpxL1 LPS.
    van Berkel ME; Schrijver EH; van Mourik A; Tesselaar K; van der Ley P; Steeghs L; Oosterwegel MA
    Vaccine; 2007 Jun; 25(24):4681-8. PubMed ID: 17499399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants.
    van der Ley P; van den Dobbelsteen G
    Hum Vaccin; 2011 Aug; 7(8):886-90. PubMed ID: 21785281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets.
    Stojkovic S; Thulin Å; Hell L; Thaler B; Rauscher S; Baumgartner J; Gröger M; Ay C; Demyanets S; Neumayer C; Huk I; Spittler A; Huber K; Wojta J; Siegbahn A; Åberg M
    Thromb Haemost; 2017 Jun; 117(7):1379-1390. PubMed ID: 28492698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative Stress Product, 4-Hydroxy-2-Nonenal, Induces the Release of Tissue Factor-Positive Microvesicles From Perivascular Cells Into Circulation.
    Ansari SA; Keshava S; Pendurthi UR; Rao LVM
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):250-265. PubMed ID: 33028097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic data from two primary cell models stimulating human monocytes suggest inhibition of oxidative phosphorylation and mitochondrial function by N. meningitidis which is partially up-regulated by IL-10.
    Gopinathan U; Øvstebø R; Brusletto BS; Olstad OK; Kierulf P; Brandtzaeg P; Berg JP
    BMC Immunol; 2017 Oct; 18(1):46. PubMed ID: 29078758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.